Circulating Testosterone as the Hormonal Basis of Sex Differences in Athletic Performance
Top Cited Papers
Open Access
- 13 July 2018
- journal article
- review article
- Published by The Endocrine Society in Endocrine Reviews
- Vol. 39 (5), 803-829
- https://doi.org/10.1210/er.2018-00020
Abstract
Elite athletic competitions have separate male and female events due to men’s physical advantages in strength, speed, and endurance so that a protected female category with objective entry criteria is required. Prior to puberty, there is no sex difference in circulating testosterone concentrations or athletic performance, but from puberty onward a clear sex difference in athletic performance emerges as circulating testosterone concentrations rise in men because testes produce 30 times more testosterone than before puberty with circulating testosterone exceeding 15-fold that of women at any age. There is a wide sex difference in circulating testosterone concentrations and a reproducible dose-response relationship between circulating testosterone and muscle mass and strength as well as circulating hemoglobin in both men and women. These dichotomies largely account for the sex differences in muscle mass and strength and circulating hemoglobin levels that result in at least an 8% to 12% ergogenic advantage in men. Suppression of elevated circulating testosterone of hyperandrogenic athletes results in negative effects on performance, which are reversed when suppression ceases. Based on the nonoverlapping, bimodal distribution of circulating testosterone concentration (measured by liquid chromatography–mass spectrometry)—and making an allowance for women with mild hyperandrogenism, notably women with polycystic ovary syndrome (who are overrepresented in elite athletics)—the appropriate eligibility criterion for female athletic events should be a circulating testosterone of <5.0 nmol/L. This would include all women other than those with untreated hyperandrogenic disorders of sexual development and noncompliant male-to-female transgender as well as testosterone-treated female-to-male transgender or androgen dopers.Keywords
This publication has 181 references indexed in Scilit:
- Sex Differences and Sex Steroids in Lung Health and DiseaseEndocrine Reviews, 2012
- Circulating Testosterone and SHBG Concentrations Are Heritable in Women: The Framingham Heart StudyJournal of Clinical Endocrinology & Metabolism, 2011
- Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndromePsychoneuroendocrinology, 2011
- The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its DisordersEndocrine Reviews, 2011
- Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography–tandem mass spectrometrySteroids, 2011
- Gender, Age, Body Mass Index, and IGF-I Individually and Jointly Determine Distinct GH Dynamics: Analyses in One Hundred Healthy AdultsJournal of Clinical Endocrinology & Metabolism, 2011
- Total Testosterone Assays in Women with Polycystic Ovary Syndrome: Precision and Correlation with HirsutismJournal of Clinical Endocrinology & Metabolism, 2010
- Are There Any Sensitive and Specific Sex Steroid Markers for Polycystic Ovary Syndrome?Journal of Clinical Endocrinology & Metabolism, 2010
- Changes in Muscle Mass, Muscle Strength, and Power but Not Physical Function Are Related to Testosterone Dose in Healthy Older MenJournal of the American Geriatrics Society, 2008
- Effects of Graded Doses of Testosterone on Erythropoiesis in Healthy Young and Older MenJournal of Clinical Endocrinology & Metabolism, 2008